What we do
About us
News & events
Investors
Careers
What we do
About us
News & events
Investors
Overview
Press releases
Events & presentations
Corporate Governance
Shareholder & stock info
Financial reports
Financial calendar
Rights Issue and Directed Issue 2023
Careers
Back
Back
Immunicum AB: Immunicum Announces Positive Interim Results from ADVANCE II Study in AML Maintenance Treatment
8:00:00 AM
Keep reading
Immunicum AB: Report from the Annual General Meeting of Immunicum AB (publ) on 10 May 2022
Read